DEF 14AThe Ballot
4D Molecular Therapeutics, Inc. files DEF 14A
Filed Apr 10, 2024 · 2y ago · Accession 0001140361-24-019090
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Ticker
- FDMT
- CIK
- 1650648
- Form type
- DEF 14A
- Filing date
- Apr 10, 2024
- Report date
- May 21, 2024
- Document
- edge20023177x1_def14a.htm
- Size
- 2.0 MB